Dr. Sudha Tallapragada, MD
What this data tells you about Dr. Tallapragada
Dr. Sudha Tallapragada is an infectious disease in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Tallapragada performed 127,935 Medicare services across 1,991 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tallapragada received a total of $1,199 from 9 pharmaceutical and/or device companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tallapragada is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 111,150 | $0 | $1 |
| Injection, dalbavancin, 5 mg | 9,600 | $12 | $31 |
| Ceftriaxone antibiotic injection | 1,672 | $0 | $35 |
| Injection, ertapenem sodium, 500 mg | 920 | $11 | $78 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 882 | $49 | $225 |
| Infusion, normal saline solution, 250 cc | 746 | $1 | $15 |
| Hospital follow-up visit, high complexity | 647 | $96 | $295 |
| Injection, cefepime hydrochloride, 500 mg | 538 | $1 | $40 |
| Hospital follow-up visit, moderate complexity | 515 | $64 | $265 |
| Office visit, established patient (30-39 min) | 402 | $94 | $384 |
| Office visit, established patient (20-29 min) | 150 | $68 | $273 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 131 | $22 | $94 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 122 | $54 | $125 |
| Refilling and maintenance of portable pump | 107 | $98 | $375 |
| New patient office visit, complex (60-74 min) | 61 | $163 | $670 |
| Blood draw (venipuncture) | 59 | $8 | $20 |
| Transitional care management services for problem of high complexity | 39 | $213 | $450 |
| Office visit, established patient, complex (40-54 min) | 35 | $130 | $544 |
| Transitional care management services for problem of at least moderate complexity | 35 | $153 | $375 |
| 5% dextrose/water (500 ml = 1 unit) | 26 | $1 | $15 |
| Nursing facility visit, moderate complexity | 24 | $85 | $170 |
| Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 21 | $123 | $250 |
| Initial hospital admission, high complexity | 19 | $140 | $375 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18 | $41 | $85 |
| Removal of inflamed or infected skin, up to 10% of body surface | 16 | $22 | $100 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (60%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tallapragada is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tallapragada experienced with daptomycin antibiotic injection?
Does Dr. Tallapragada receive payments from pharmaceutical companies?
How do Dr. Tallapragada's costs compare to other infectious diseases in Sarasota?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology